GAVI unfreezes payments. Key criticism remains unanswered

Last December, following a critical study published in The Lancet suggesting that GAVI had overpaid countries for child immunisation by USD 140 million, GAVI froze its payment scheme. Now GAVI has decided to resume payments. But the study’s authors say their key finding remains unaddressed.